Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Section Editors
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
EXPERIMENTAL RESEARCH
Reinforcement of osteogenic and mechanical properties of calcium phosphate cement with palm tocotrienol
1
Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, Cheras, Kuala Lumpur, Malaysia
2
Department of Anatomy, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, Cheras, Kuala Lumpur, Malaysia
Submission date: 2025-01-13
Final revision date: 2025-03-29
Acceptance date: 2025-04-06
Online publication date: 2025-05-21
Corresponding author
Sok Kuan Wong
Department of Pharmacology Faculty of Medicine Universiti Kebangsaan Malaysia Jalan Yaacob Latif Bandar Tun Razak 56000 Cheras Kuala Lumpur, Malaysia Phone: +603-9145 9566
Department of Pharmacology Faculty of Medicine Universiti Kebangsaan Malaysia Jalan Yaacob Latif Bandar Tun Razak 56000 Cheras Kuala Lumpur, Malaysia Phone: +603-9145 9566
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Calcium phosphate cement (CPC) is a promising bone substitute but lacks osteogenicity and mechanical strength. This study investigated the effects of CPC doped with palm tocotrienol, a bone-protective agent, on bone regeneration in ovariectomised rats with tibial defects.
Material and methods:
Female Sprague-Dawley rats were divided into sham-operated controls, ovariectomised rats (OVX), ovariectomised rats with bone defects implanted with CPC (OVX + CPC) and ovariectomised rats with bone defects implanted with palm tocotrienol-doped CPC (OVX + CPC/T3). A tibial bone defect was created 11 weeks after ovariectomy.
Results:
Whole-body BMC was higher in OVX + CPC (10.89 ±0.07 g) and OVX + CPC/T3 (11.26 ±0.07 g) than OVX (10.24 ±0.14 g) (p < 0.05). Whole-body BMD of OVX + CPC/T3 (0.175 ±0.003 to 0.182 ±0.003 g/cm2), left tibia BMC of OVX + CPC (0.308 ±0.016 to 0.343 ±0.022 g) and OVX + CPC/T3 (0.313 ±0.020 to 0.343 ±0.016 g) increased from week 11 to 15 (p < 0.05). The OVX + CPC/T3 group had higher bone stiffness (23.31 ±1.07 vs. 8.35 ±3.84 N/mm), collagen (scoring: 3 ±0.75 vs. 2 ±0), trabecular bone formation (scoring: 3 ±0 vs. 2 ±0), and trabecular bone volume (36.30 ±3.58 vs. 20.86 ±1.03%) but lower osteoclast surface (1.65 ±0.49 vs. 6.60 ±1.36%) than OVX (p < 0.05). Tibial BMP-2 in OVX + CPC/T3 (78.96 ±8.30 pg/mg protein) was higher than OVX (30.65 ±3.69 pg/mg protein) and OVX + CPC (48.09.96 ±8.39 pg/mg protein) (p < 0.05). Tibial Runx-2 in OVX + CPC/T3 (2589.75 ±204.74 pg/mg protein) was higher than OVX (1652.97 ±156.85 pg/mg protein) and OVX + CPC (1845.77 ±158.17 pg/mg protein) (p < 0.05).
Conclusions:
Palm tocotrienol enhanced the osteogenic properties of CPC, promoting collagen and trabecular bone formation in ovariectomised rats with bone defects. These findings suggest its potential to overcome the drawbacks of CPC and promote bone regeneration.
Calcium phosphate cement (CPC) is a promising bone substitute but lacks osteogenicity and mechanical strength. This study investigated the effects of CPC doped with palm tocotrienol, a bone-protective agent, on bone regeneration in ovariectomised rats with tibial defects.
Material and methods:
Female Sprague-Dawley rats were divided into sham-operated controls, ovariectomised rats (OVX), ovariectomised rats with bone defects implanted with CPC (OVX + CPC) and ovariectomised rats with bone defects implanted with palm tocotrienol-doped CPC (OVX + CPC/T3). A tibial bone defect was created 11 weeks after ovariectomy.
Results:
Whole-body BMC was higher in OVX + CPC (10.89 ±0.07 g) and OVX + CPC/T3 (11.26 ±0.07 g) than OVX (10.24 ±0.14 g) (p < 0.05). Whole-body BMD of OVX + CPC/T3 (0.175 ±0.003 to 0.182 ±0.003 g/cm2), left tibia BMC of OVX + CPC (0.308 ±0.016 to 0.343 ±0.022 g) and OVX + CPC/T3 (0.313 ±0.020 to 0.343 ±0.016 g) increased from week 11 to 15 (p < 0.05). The OVX + CPC/T3 group had higher bone stiffness (23.31 ±1.07 vs. 8.35 ±3.84 N/mm), collagen (scoring: 3 ±0.75 vs. 2 ±0), trabecular bone formation (scoring: 3 ±0 vs. 2 ±0), and trabecular bone volume (36.30 ±3.58 vs. 20.86 ±1.03%) but lower osteoclast surface (1.65 ±0.49 vs. 6.60 ±1.36%) than OVX (p < 0.05). Tibial BMP-2 in OVX + CPC/T3 (78.96 ±8.30 pg/mg protein) was higher than OVX (30.65 ±3.69 pg/mg protein) and OVX + CPC (48.09.96 ±8.39 pg/mg protein) (p < 0.05). Tibial Runx-2 in OVX + CPC/T3 (2589.75 ±204.74 pg/mg protein) was higher than OVX (1652.97 ±156.85 pg/mg protein) and OVX + CPC (1845.77 ±158.17 pg/mg protein) (p < 0.05).
Conclusions:
Palm tocotrienol enhanced the osteogenic properties of CPC, promoting collagen and trabecular bone formation in ovariectomised rats with bone defects. These findings suggest its potential to overcome the drawbacks of CPC and promote bone regeneration.
REFERENCES (64)
1.
Feng X, McDonald JM. Disorders of bone remodeling. Annu Rev Pathol 2011; 6: 121-45.
2.
Wong SK, Wong YH, Chin KY, Ima-Nirwana S. A review on the enhancement of calcium phosphate cement with biological materials in bone defect healing. Polymers (Basel) 2021; 13: 3075.
3.
Baker CE, Moore-Lotridge SN, Hysong AA, et al. Bone fracture acute phase response-a unifying theory of fracture repair: clinical and scientific implications. Clin Rev Bone Miner Metab 2018; 16: 142-58.
4.
Molitoris KH, Huang M, Baht GS. Osteoimmunology of fracture healing. Curr Osteoporos Rep 2024; 22: 330-9.
5.
Pouresmaeili F, Kamalidehghan B, Kamarehei M, Goh YM. A comprehensive overview on osteoporosis and its risk factors. Ther Clin Risk Manag 2018; 14: 2029-49.
6.
Thormann U, El Khawassna T, Ray S, et al. Differences of bone healing in metaphyseal defect fractures between osteoporotic and physiological bone in rats. Injury 2014; 45: 487-93.
7.
Kido HW, Bossini PS, Tim CR, et al. Evaluation of the bone healing process in an experimental tibial bone defect model in ovariectomized rats. Aging Clin Exp Res 2014; 26: 473-81.
8.
Zura R, Braid-Forbes MJ, Jeray K, et al. Bone fracture nonunion rate decreases with increasing age: a prospective inception cohort study. Bone 2017; 95: 26-32.
9.
Zura R, Xiong Z, Einhorn T, et al. Epidemiology of fracture nonunion in 18 human bones. JAMA Surg 2016; 151: e162775.
10.
Nikolaou VS, Efstathopoulos N, Kontakis G, Kanakaris NK, Giannoudis PV. The influence of osteoporosis in femoral fracture healing time. Injury 2009; 40: 663-8.
11.
Salamanca E, Hsu CC, Huang HM, et al. Bone regeneration using a porcine bone substitute collagen composite in vitro and in vivo. Sci Rep 2018; 8: 984.
12.
Haugen HJ, Lyngstadaas SP, Rossi F, Perale G. Bone grafts: which is the ideal biomaterial? J Clin Periodontol 2019; 46 Suppl 21: 92-102.
13.
Xue N, Ding X, Huang R, et al. Bone tissue engineering in the treatment of bone defects. Pharmaceuticals (Basel) 2022; 15: 879.
14.
Sohn HS, Oh JK. Review of bone graft and bone substitutes with an emphasis on fracture surgeries. Biomater Res 2019; 23: 9.
15.
Xu HHK, Wang P, Wang L, et al. Calcium phosphate cements for bone engineering and their biological properties. Bone Research 2017; 5: 17056.
16.
Md Dali SS, Wong SK, Chin KY, Ahmad F. The osteogenic properties of calcium phosphate cement doped with synthetic materials: a structured narrative review of preclinical evidence. Int J Mol Sci 2023; 24: 7161.
17.
Saud Gany SL, Chin KY, Tan JK, Aminuddin A, Makpol S. Preventative and therapeutic potential of tocotrienols on musculoskeletal diseases in ageing. Front Pharmacol 2023; 14: 1290721.
18.
Qureshi AA, Khan DA, Silswal N, Saleem S, Qureshi N. Evaluation of pharmacokinetics, and bioavailability of higher doses of tocotrienols in healthy fed humans. J Clin Exp Cardiol 2016; 7: 434.
19.
Nakatomi T, Itaya-Takahashi M, Horikoshi Y, et al. The difference in the cellular uptake of tocopherol and tocotrienol is influenced by their affinities to albumin. Sci Rep 2023; 13: 7392.
20.
Wong SK, Mohamad NV, Ibrahim N, Chin KY, Shuid AN, Ima-Nirwana S. The molecular mechanism of vitamin E as a bone-protecting agent: a review on current evidence. Int J Mol Sci 2019; 20: 1453.
21.
Chin KY, Ima-Nirwana S. The biological effects of tocotrienol on bone: a review on evidence from rodent models. Drug Des Devel Ther 2015; 9: 2049-61.
22.
Mohamad NV, Ima-Nirwana S, Chin KY. Therapeutic potential of annatto tocotrienol with self-emulsifying drug delivery system in a rat model of postmenopausal bone loss. Biomed Pharmacother 2021; 137: 111368.
23.
Ekeuku SO, Mohd Ramli ES, Abdullah Sani N, Abd Ghafar N, Soelaiman IN, Chin KY. Tocotrienol as a protecting agent against glucocorticoid-induced osteoporosis: a mini review of potential mechanisms. Molecules 2022; 27: 5862.
24.
Norazlina M, Maizatul-Neza J, Azarina A, Nazrun AS, Norliza M, Ima-Nirwana S. Effects of vitamin E on receptor activator of nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG) in rats treated with nicotine. Med J Malaysia 2010; 65: 14-7.
25.
Wong SK, Chin KY, Suhaimi FH, Ahmad F, Ima-Nirwana S. The effects of vitamin E from Elaeis guineensis (Oil Palm) in a rat model of bone loss due to metabolic syndrome. Int J Environ Res Public Health 2018; 15: 1828.
26.
Wong SK, Chin KY, Suhaimi FH, Ahmad F, Ima-Nirwana S. Exploring the potential of tocotrienol from Bixa orellana as a single agent targeting metabolic syndrome and bone loss. Bone 2018; 116: 8-21.
27.
Mohamad S, Shuid AN, Mokhtar SA, Abdullah S, Soelaiman IN. Tocotrienol supplementation improves late-phase fracture healing compared to alpha-tocopherol in a rat model of postmenopausal osteoporosis: a biomechanical evaluation. Evid Based Complement Alternat Med 2012; 2012: 372878.
28.
Ibrahim N, Mohamed N, Soelaiman IN, Shuid AN. The effects of targeted deliveries of lovastatin and tocotrienol on ossification-related gene expressions in fracture healing in an osteoporosis rat model. Int J Environ Res Public Health 2015; 12: 12958-76.
29.
Wong SK, Chin KY, Ahmad F, Ima-Nirwana S. Regulation of inflammatory response and oxidative stress by tocotrienol in a rat model of non-alcoholic fatty liver disease. J Funct Foods 2020; 74: 104209.
30.
Wong SK, Fikri NIA, Munesveran K, et al. Effects of tocotrienol on osteocyte-mediated phosphate metabolism in high-carbohydrate high-fat diet-induced osteoporotic rats. J Funct Foods 2022; 96: 105213.
31.
Luo J, Engqvist H, Persson C. A ready-to-use acidic, brushite-forming calcium phosphate cement. Acta Biomater 2018; 81: 304-14.
32.
Zhu J, Zhang C, Jia J, et al. Osteogenic effects in a rat osteoporosis model and femur defect model by simvastatin microcrystals. Ann N Y Acad Sci 2021; 1487: 31-42.
33.
Ibrahim N, Mohamed IN, Mohamed N, Mohd Ramli ES, Shuid AN. The effects of aqueous extract of Labisia Pumila (Blume) Fern.-Vill. Var. Alata on wound contraction, hydroxyproline content and histological assessments in superficial partial thickness of second-degree burn model. Front Pharmacol 2022; 13: 968664.
34.
Schindelin J, Arganda-Carreras I, Frise E, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods 2012; 9: 676-682.
35.
Mishchenko O, Yanovska A, Kosinov O, et al. Synthetic calcium-phosphate materials for bone grafting. Polymers (Basel) 2023; 15: 3822.
36.
Leeners B, Geary N, Tobler PN, Asarian L. Ovarian hormones and obesity. Hum Reprod Update 2017; 23: 300-21.
37.
Chen Y, Heiman ML. Increased weight gain after ovariectomy is not a consequence of leptin resistance. Am J Physiol Endocrinol Metab 2001; 280: E315-22.
38.
Ekeuku SO, Chin KY, Qian J, et al. Normalisation of high bone remodelling due to oestrogen deficiency by Traditional Chinese Formulation Kang Shuai Lao Pian in ovariectomised rats. Int J Med Sci 2022; 19: 1648-59.
39.
Holmes CJ, Racette SB. The utility of body composition assessment in nutrition and clinical practice: an overview of current methodology. Nutrients 2021; 13: 2493.
40.
Ibrahim N, Mohd Noor H, Shuid AN, et al. Osteoprotective effects in postmenopausal osteoporosis rat model: oral tocotrienol vs. intraosseous injection of tocotrienol-poly lactic-co-glycolic acid combination. Front Pharmacol 2021; 12: 706747.
41.
Curtis EM, Harvey NC, D’Angelo S, et al. Bone mineral content and areal density, but not bone area, predict an incident fracture risk: a comparative study in a UK prospective cohort. Arch Osteoporos 2016; 11: 39.
42.
Li L, Peng X, Qin Y, et al. Acceleration of bone regeneration by activating Wnt/-catenin signalling pathway via lithium released from lithium chloride/calcium phosphate cement in osteoporosis. Sci Rep 2017; 7: 45204.
43.
Saif AM, Norazlina M, Ima-Nirwana S. Quantification of bone histomorphometric parameters using the weibel technique in animals. Med Health 2016; 11: 278-88.
44.
Abdul-Majeed S, Mohamed N, Soelaiman IN. Effects of tocotrienol and lovastatin combination on osteoblast and osteoclast activity in estrogen-deficient osteoporosis. Evid Based Complement Alternat Med 2012; 2012: 960742.
45.
Muhammad N, Luke DA, Shuid AN, Mohamed N, Soelaiman IN. Two different isomers of vitamin e prevent bone loss in postmenopausal osteoporosis rat model. Evid Based Complement Alternat Med 2012; 2012: 161527.
46.
Mohd Ramli ES, Ahmad F, Salleh NI, et al. Beneficial effects of annatto (Bixa Orellana) tocotrienol on bone histomorphometry and expression of genes related to bone formation and resorption in osteoporosis induced by dexamethasone. Int J Med Res Health Sci 2018; 7: 85-100.
47.
Lee JY, Hong SH. Hematopoietic stem cells and their roles in tissue regeneration. Int J Stem Cells 2020; 13: 1-12.
48.
Brown MG, Brady DJ, Healy KM, Henry KA, Ogunsola AS, Ma X. Stem cells and acellular preparations in bone regeneration/fracture healing: current therapies and future directions. Cells 2024; 13: 1045.
49.
Sarkar SK, Lee BY, Padalhin AR, et al. Brushite-based calcium phosphate cement with multichannel hydroxyapatite granule loading for improved bone regeneration. J Biomater Appl 2016; 30: 823-37.
50.
Olszta MJ, Cheng X, Jee SS, et al. Bone structure and formation: a new perspective. Materials Sci Engineering R Rep 2007; 58: 77-116.
51.
Shahrim Z, Makpol S, Tan GC, Muhammad NA, Hasan ZAA. Topical application of the palm tocotrienol-rich fraction (TRF) enhances cutaneous wound healing in type 2 diabetic mice. J Oil Palm Res 2022; 34: 546-61.
52.
Schneider MR. Von Kossa and his staining technique. Histochem Cell Biol 2021; 156: 523-6.
53.
Ekeuku SO, Nor Muhamad ML, Aminuddin AA, et al. Effects of emulsified and non-emulsified palm tocotrienol on bone and joint health in ovariectomised rats with monosodium iodoacetate-induced osteoarthritis. Biomed Pharmacother 2024; 170: 115998.
54.
Zhang Y, Shen L, Mao Z, et al. Icariin enhances bone repair in rabbits with bone infection during post-infection treatment and prevents inhibition of osteoblasts by vancomycin. Front Pharmacol 2017; 8: 784.
55.
Chin KY, Abdul-Majeed S, Mohamed N, Ima-Nirwana S. The effects of tocotrienol and lovastatin co-supplementation on bone dynamic histomorphometry and bone morphogenetic protein-2 expression in rats with estrogen deficiency. Nutrients 2017; 9: 143.
56.
Wan Hasan WN, Chin KY, Abd Ghafar N, Soelaiman IN. Annatto-derived tocotrienol promotes mineralization of MC3T3-E1 cells by enhancing BMP-2 protein expression via inhibiting RhoA activation and HMG-CoA reductase gene expression. Drug Des Devel Ther 2020; 14: 969-76.
57.
Abukhadir SS, Mohamed N, Makpol S, Muhammad N. Effects of palm vitamin e on bone-formation-related gene expression in nicotine-treated rats. Evid Based Complement Alternat Med 2012; 2012: 656025.
58.
Mohamad NV, Soelaiman IN, Chin KY. Effects of tocotrienol from Bixa orellana (annatto) on bone histomorphometry in a male osteoporosis model induced by buserelin. Biomed Pharmacother 2018; 103: 453-62.
59.
Singh S, Kumar D, Lal AK. Serum osteocalcin as a diagnostic biomarker for primary osteoporosis in women. J Clin Diagn Res 2015; 9: Rc04-07.
60.
Tateiwa D, Nakagawa S, Tsukazaki H, et al. A novel BMP-2-loaded hydroxyapatite/beta-tricalcium phosphate microsphere/hydrogel composite for bone regeneration. Sci Rep 2021; 11: 16924.
61.
Jiang C, Zhu S, Zhan W, Lou L, Li A, Cai J. Comparative analysis of bone turnover markers in bone marrow and peripheral blood: implications for osteoporosis. J Orthop Surg Res 2024; 19: 163.
62.
Hogan HA, Ruhmann SP, Sampson HW. The mechanical properties of cancellous bone in the proximal tibia of ovariectomized rats. J Bone Miner Res 2000; 15: 284-92.
63.
Wong SK, Chin KY, Ima-Nirwana S. The effects of tocotrienol on bone peptides in a rat model of osteoporosis induced by metabolic syndrome: the possible communication between bone cells. Int J Environ Res Public Health 2019; 16: 3313.
64.
Wong SK, Kamisah Y, Mohamed N, et al. Potential role of tocotrienols on non-communicable diseases: a review of current evidence. Nutrients 2020; 12: 259.
Share
RELATED ARTICLE
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
